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Introduction: Acute renal infarction (ARI) is an uncommon disease, whose real incidence is
probably higher than expected. It is associated with poor prognosis in a high percentage of
cases.
Objectives: To describe the main clinical, biochemical and radiologic features and to deter-
mine which factors are associated with poor prognosis (death or permanent renal injury).
Materials and methods: The following is a retrospective, observational, single-center study.
All  patients diagnosed with ARI by contrast-enhanced computed tomography (CT) over
an  18-year period were included. Patients were classiﬁed according to the cardiac or non-
cardiac origin of their disease. Clinical, biochemical and radiologic features were analysed,
and  multiple logistic regression model was used to determine factors associated with poor
prognosis.
Results: A total of 62 patients were included, 30 of which had a cardiac origin. Other 32
patients with non-cardiac ARI were younger, had less comorbidity, and were less frequently
treated with oral anticoagulants. CT scans estimated mean injury extension at 35%, with no
differences observed between groups. A total of 38% of patients had an unfavourable out-
come, and the main determinants were: Initial renal function (OR = 0.949; CI 95% 0.918–0.980;us treatment with oral anticoagulants (OR = 0.135; CI 95% 0.032–0.565;p  = 0.002), and previop  = 0.006).
Conclusions: ARI is a rare clinical condition with non-speciﬁc symptoms, and it is not asso-
ciated with cardiological disease or arrhythmias in more than half of cases. A substantial
 Please cite this article as: Caravaca-Fontán F, Pampa Saico A, Elías Trivin˜o S, Galeano Álvarez C, Gomis Couto A, Pecharromán de las
eras  I, et al. Infarto renal agudo: características clínicas y factores pronósticos. Nefrología. 2016;36:141–148.
∗ Corresponding author.
E-mail address: fcaravacaf@gmail.com (F. Caravaca-Fontán).
013-2514/© 2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
142  n e f r o l o g i a. 2 0 1 6;3 6(2):141–148
proportion of patients have unfavourable outcomes, and the initial renal function is one of
the  main prognostic factors.
©  2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Infarto  renal  agudo:  características  clínicas  y  factores  pronósticos
Palabras clave:
Anticoagulación oral
Fibrilación auricular
Embolia renal
Infarto renal agudo
Insuﬁciencia renal aguda
r  e  s  u  m  e  n
Introducción: El infarto renal agudo (INRA) es una patología de diagnóstico infrecuente, cuya
incidencia real es probablemente superior a la detectada, y que asocia una evolución des-
favorable en un alto porcentaje de casos.
Objetivos: Describir las principales características clínicas, bioquímicas y radiológicas, y
determinar qué factores se asocian a una peor evolución (muerte o deterioro permanente
de  la función renal).
Material y métodos: Estudio retrospectivo y observacional, que incluyó a todos los pacientes
diagnosticados de INRA mediante TAC con contraste en un único hospital durante 18 an˜os.
Los  pacientes fueron clasiﬁcados según el origen cardiogénico o no cardiogénico del INRA. Se
analizaron las principales características clínicas, bioquímicas y radiológicas, y, mediante
un  modelo de regresión logística multivariante, se determinaron los factores asociados a
una peor evolución.
Resultados: Se incluyeron 62 casos, de los que 30 fueron de origen cardiogénico. Los 32
pacientes con INRA no cardiogénico eran más jóvenes, con menos comorbilidad y menor fre-
cuencia de tratamiento previo con anticoagulación. La extensión media de dan˜o isquémico
por  radiología fue del 35%, sin observarse diferencias entre los subgrupos etiológicos. El
38%  de los pacientes tuvo una evolución desfavorable, y los principales determinantes
fueron: la función renal al diagnóstico (eGFR) (OR = 0,949; IC 95%: 0,918–0,980; p = 0,002) y
la  anticoagulación oral antes del episodio agudo (OR = 0,135; IC 95%: 0,032–0,565; p = 0,006).
Conclusiones: El INRA es una patología infrecuente, con manifestaciones clínicas poco especí-
ﬁcas y, en más de la mitad de los casos, no asociada a enfermedad cardiaca o arritmias. Una
alta  proporción de pacientes evoluciona desfavorablemente. La función renal al diagnóstico
es  uno de los principales factores pronósticos.
©  2015 Sociedad Espan˜ola de Nefrología. Publicado por Elsevier España, S.L.U. Este es un
artículo Open Access bajo la licencia CC BY-NC-NDIntroduction
Acute renal infarction (ARI) refers to ischaemic damage of the
renal parenchyma caused by the sudden interruption of blood
ﬂow. It is a rare cause of acute kidney failure, with an inci-
dence rate in published series ranging from 0.007% to 1.4%.1,2
However, its incidence is probably higher, due to its difﬁcult
diagnosis.
It is commonly manifested by the sudden onset of dif-
fuse abdominal or lumbar pain together with neurovegetative
symptoms that cannot be well controlled with analgesics;
occasionally fever is present. This set of non-speciﬁc
symptoms is some times interpreted as other common con-
ditions such as urolithiasis, pyelonephritis or gastrointestinal
diseases.3
The two major causes of ARI are renal embolism, often
originated at the heart and triggered by atrial ﬁbrillation,
and renal artery thrombosis, caused by traumatic lesions or
lesions originated during diagnostic and therapeutic proce-
dures. Other common causes include renal artery dissection
or ﬁbromuscular dysplasia and spontaneous thrombosis(http://creativecommons.org/licenses/by-nc-nd/4.0/).
associated with hypercoagulability. Nevertheless, the cause
of ARI is impossible to determine in 29–59% of cases.4–8 Early
treatment with anticoagulants or ﬁbrinolytics may reverse
the ischaemia and improve prognosis.9,10 Unfortunately,
diagnosis is often delayed, which is why ARI should always be
included in the differential diagnosis of patients presenting
with the aforementioned symptoms.
The present study includes of 62 patients with ARI in native
kidneys (excluding transplanted kidneys) diagnosed at Hospi-
tal Ramón y Cajal over an 18-year period. The study objectives
were to describe the main clinical, biochemical and radio-
logical features of this disease, to analyse clinical differences
based on aetiology and to determine which factors are associ-
ated with poor prognosis (death or permanent renal function
impairment).
Material  and  methodsARI patients diagnosed by radiological methods from 1996 to
2014 were selected. Kidney transplant patients were excluded.
1 6;3  6(2):141–148 143
i
C
h
i
v
p
u
p
a
p
A
k
d
i
1
(
c
n
(
l
f
o
o
n
a
s
d
o
t
d
F
d
c
d
r
Fig. 2 – Transverse contrast-enhanced CT scan showing
ﬁndings suggestive of renal infarction with involvement of
most of the left kidney. Cortical rim sign can be appreciated
(arrow). The degree of damage in this case would be 3/6
(50% of the total renal parenchyma).n e f r o l o g i a. 2 0 
Baseline characteristics were obtained from the med-
cal records, including demographic data, the Charlson
omorbidity Index, cardiovascular risk factors (history of
ypertension, diabetes mellitus, dyslipidaemia, smoking,
schaemic heart disease, arrhythmias, thrombophilia and pre-
ious embolisms), history of chronic kidney disease and
revious treatment with antiplatelet agents or oral anticoag-
lation was also recorded.
ARI was diagnosed by axial or spiral computed tomogra-
hy (CT scan) depending on the study period and with the
dministration of an intravenous contrast.
The extent of ischaemic injury was estimated in each
atient by dividing the kidney into six segments, such that
RI of the renal poles, with no involvement of the rest of the
idney or the contralateral kidney, was considered to have 1/6
egree of damage (17%) (Figs. 1 and 2). Thus, the estimated
njury extent for each patient could theoretically range from
/6 (17%) to 6/6 (100%).
Baseline lab work included: haematological parameters
haemoglobin, total leucocyte count, neutrophil and platelet
ounts); and biochemical parameters with serum creati-
ine, lactate dehydrogenase (LDH) and C-reactive protein
CRP). Renal function was estimated using the glomeru-
ar ﬁltration rate (eGFR) by applying the 4-variable MDRD
ormula.11 Impaired renal function was deﬁned as an eGFR
f <60 ml/min/1.73 m2 at diagnosis or during the ﬁrst week
f progression in all patients with no previous history of kid-
ey disease. Conventional laboratory methods were applied,
lthough they differed depending on the year in which the
tudy events occurred.
Patients were assigned to 2 subgroups according to the car-
iac or non-cardiac origin of their ARI, and the characteristics
f these subgroups were compared.
The outcome data was censored 6 months after the ini-
ial onset of ARI. Unfavourable outcome was deemed to be
eath from any cause or the non-recovery of partial or total
ig. 1 – Contrast-enhanced CT scan showing perfusion
efect in the lower pole of the left kidney (arrow)
orresponding to the area of the renal infarction. The
egree of damage in this case would be 1/6 (17% of the total
enal parenchyma).renal function after 6 months of the event. Partial recovery was
deﬁned as renal impairment (eGFR < 60 ml/min/1.73 m2), or an
eGFR value lower than the ﬁgure obtained before the onset of
ARI in patients with a known history of renal impairment.
Study  design  and  statistical  analysis
This is a retrospective, observational study that describes the
clinical and biochemical characteristics of patients diagnosed
with ARI.
Student’s t-test or the Mann–Whitney non-parametric test
was used to compare 2 continuous independent variables for
unpaired samples, depending on the distribution character-
istics of the variables. The chi-square test with continuity
correction was used to compare discrete variables.
A multivariate logistic regression model was used to estab-
lish the clinical parameters associated to an unfavourable
progression following acute renal infarction, and the fol-
lowing independent variables were considered: age, gender,
comorbidity index, days since the onset of symptoms to treat-
ment initiation, aetiological origin (cardiac or non-cardiac),
glomerular ﬁltration rate at diagnosis, total leucocyte count,
LDH, antiplatelet agents and oral anticoagulation prior to the
acute episode.
To prevent collinearity, the model excluded neutrophil
count and the extent of kidney damage by radiology (see
Results section). To prevent overﬁtting, variables were forced
into the multivariate model with a signiﬁcance of at least
p < 0.01. The variables in the multivariate model were chosen
automatically by conditional progressive inclusion (forward).
Data were presented as mean and standard deviation (±SD)
or as median and interquartile ranges or maximum and
minimum values. p < 0.05 was considered to be statistically
signiﬁcant.
IBM SPSS version 21 software was used to conduct the sta-
tistical analysis.
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Table 1 – Demographic and clinical characteristics of all patients and by aetiological subgroup.
% Total Cardiac origin Non-cardiac origin p*
Number 62 30 (48) 32 (52)
Age in years 67 ± 16 77 ± 11 58 ± 14 <0.0001
Gender (male) 48  43 53 0.441
Charlson indexa 5 [2.75–7] 6 [4–7] 3  [1–5.75] 0.005
Hypertension 69 83 56 0.042
Diabetes mellitus 22 30 16 0.2900
Dyslipidaemia 32 50 16 0.009
Smoking 23 13 31 0.167
Ischaemic heart disease 23 40 6 0.004
Previous history of arrhythmia 37 70 6 <0.0001
Previous history of embolism 21 20 22 1.000
History of chronic kidney disease 11 17 6 0.3700
Prior antiplatelet therapy 32 28 37 0.6500
Prior anticoagulant therapy 32 53 13 0.002
Abdominal pain 97 100 94 0.501
Flank pain 90 93 88 0.729
Nausea 60 60 59 1.000
Vomiting 34 37 31 0.856
Fever 23 20 25 0.868
Days since onsetb 1 [<1–10] 1.5 [1–6] 1 [<1–10] 0.651
Systolic blood pressure at diagnosis in mmHg 149 ± 32 153 ± 27 145 ± 37 0.296
Diastolic blood pressure at diagnosis in mmHg 77 ± 18 79 ± 16 76 ± 20 0.465
Heart rate at diagnosis in bpm 80 ± 19 82 ± 18 77 ± 19 0.305
Baseline serum creatinine in mg/dl 1.44 ± 0.71 1.63 ± 0.76 1.26 ± 0.60 0.035
eGFR in ml/min/173 m2 51.1 ± 22.1 41.5 ± 17.4 60.1 ± 22.5 0.001
Total white blood cell count per mm3 13,035 ± 5051 12,543 ± 3558 13,497 ± 6157 0.462
Neutrophils per mm3 10,334 ± 5107 9754 ± 3727 10,879 ± 6140 0.391
LDH I/U 841 ± 486 999 ± 531 693 ± 392 0.012
C-reactive proteina in mg/l 76 [32–206]a 127 [48–220]c 72 [29–132]d 0.287
Extent of kidney damage by CT 35 ± 17 36 ± 16 34 ± 19 0.607
a Median and interquartile ranges.
b Median and maximum and minimum values.
c Measured in 19 patients.
d Measured in 13 patients.
∗ Statistical signiﬁcance when comparing the subgroups.
Results
Demographic  and  clinical  characteristics  of  the  ARI
patients
62 patients diagnosed with ARI in native kidneys were iden-
tiﬁed in the study period. The demographic and clinical
characteristics are shown in Table 1.
The number of ARI diagnoses increased with each passing
year of the study period. By analysing ARI prevalence in 4-year
periods, the vast majority (48 cases) were diagnosed in the last
8 years.
Embolic ARI of cardiac origin was diagnosed in 30 patients
(48%). Atrial ﬁbrillation was the only associated arrhythmia,
and ARI was the clinical manifestation of this arrhythmia in
48% of cases. The triggering factor leading to embolism forma-
tion was probably poor anticoagulation control. There were no
cases of endocarditis.
The associated conditions of the 32 cases (52%) of ARI
of non-cardiac origin were: damage or lesion of the renal
arteries caused by aortic and renal dissection (6 cases); post
abdominal surgery (4 cases); polyarteritis nodosa (1 case);
renal artery stenosis/thrombosis (3 cases); thrombophilia (1case of polycythaemia and 7 cases of hereditary coagulation
disorders); septic shock (1 case), neoplasms (5 cases) and
unknown origin (4 cases).
Patients with ARI of non-cardiac origin were younger,
with fewer comorbidities and fewer cardiovascular risk fac-
tors than patients with ARI of cardiac origin (Table 1). 53% of
patients with ARI of cardiac origin were already being treated
with oral anticoagulants versus just 13% of patients with ARI
of non-cardiac origin. The only anticoagulant administered
was  acenocoumarol. No differences in treatment rates with
antiplatelet agents were observed.
95% of patients with ARI of cardiac origin who  were taking
oral anticoagulation had an INR below the therapeutic range
at diagnosis. Just one patient with ARI of cardiac origin had
an INR within therapeutic range at diagnosis, although symp-
toms had manifested 72 h previously.
87% of patients were diagnosed in the Emergency Depart-
ment and the remainder in an inpatient setting (Internal
Medicine, Surgery). No signiﬁcant differences in diagnostic
delay between the inpatient setting and the emergy depart-
ment were observed.
The most common symptoms were abdominal pain, ﬂank
pain and nausea (Table 1). Vomiting and fever were less com-
mon. No differences in general symptoms were observed
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Table 2 – Clinical, biochemical and radiological characteristics of patients with favourable and unfavourable combined
clinical course (death, or partial or total renal function impairment at 6 months post-ARI).
Favourable Unfavourable p*
Patients, (%) 38 (61) 24 (39)
Age (years) 65 ± 18 70 ± 12 0.205
Gender, % (male) 45 54 0.469
Charlson index 5 [1.75–7] 5 [34,567] 0.337
Cardiac/non-cardiac origin 19/19  11/13 0.749
Days since onset to diagnosisa 2 [1225] 1  [1,2] 0.358
Initial serum creatinine, mg/dl 1.21 ± 0.42 1.79 ± 0.91 0.001
Initial eGFR, ml/min/1.73 m2 57.4 ± 19.8 41.0 ± 22.2 0.004
Total white blood cell count, per mm3 11,964 ± 3770 14,730 ± 6317 0.035
Neutrophil count, per mm3 9058 ± 3892 12,356 ± 6152 0.012
LDH, I/U 772 ± 460 951 ± 515 0.159
C-reactive protein,a mg/l 73 [25–146]b 155 [73–226]c 0.070
Radiological assessment of extent of damage, % 30 ± 12 43 ± 19 0.003
Prior antiplatelet therapy, % 34 29 0.679
Prior oral anticoagulation therapy, % 42 17 0.071
a Median and interquartile ranges.
b Analysed in 22 patients.
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Nc Analysed in 10 patients.
∗ Statistical signiﬁcance when comparing the subgroups.
etween patients with ARI of cardiac and non-cardiac origin
Table 1). There was also no difference between the subgroups
n terms of diagnostic delay, which ranged from fewer than 2 h
o 10 days, with a median of 1–1.5 days.
Impaired kidney function at diagnosis was observed in 35
atients (65%) with no previous history of kidney disease. Kid-
ey function (eGFR) at the start of the episode was signiﬁcantly
ower, and serum LDH concentrations higher, in patients with
RI of cardiac origin (Table 1). However, the leucocyte, neu-
rophil and C-reactive protein counts did not differ between
he subgroups.
Estimated mean extent of ischaemic damage measured
y CT scan was 35% (2/6 of the total renal parenchyma), with
eripheral wedge-shaped hypoperfusion present in 70% of
ases, global involvement in 21% of cases and multifocal
nvolvement in 9% of cases. All patients had two native
idneys and there were no cases of previously reported renal
trophy. No differences were found between the subgroups in
erms of predominant involvement of the left or right kidney
Table 1).
There was an inverse and linear correlation between this
adiological assessment of ischaemic damage and the eGFR
R = −0.39; p = 0.001).
Following ARI diagnosis, anticoagulation with intravenous
eparin sodium was started (to try to maintain activated
hromboplastin time at 1.5–2 times normal), before introduc-
ng oral anticoagulation (acenocoumarol to achieve INR
etween 2 and 2.5). Only 4 patients underwent local ﬁbrino-
ysis with urokinase infusion (starting dose of 200,000 IU and
ubsequent perfusion of 100,000 IU/h for 6 h). Use of ﬁbrinoly-
is was conditioned by the experience of the attending medical
eam, given the associated risks, and particularly as ARI had
ccurred in less than 24 h. Three out of the 4 patients, were
uccessfully treated, with complete recovery of renal func-
ion. The fourth patient experienced upper gastrointestinal
leeding which prompted the suspension of the treatment.
o patient underwent surgical revascularisation.Determining  factors  for  an  unfavourable  outcome
The outcomes of 24 patients (39%) with ARI were unfavourable:
8 deaths, 5 end up with advanced renal failure and 14 cases
had partially recovered renal function at 6 months (3 patients
with kidney failure died).
Extrarenal embolisms (ischaemic stroke, mesenteric
ischaemia, embolisms in the lower limbs), developed in
9 patients (15%) no differences were found between the
subgroups.
Table 2 shows the differences between patients with
favourable and unfavourable combined clinical course. No
demographic differences were found in the comorbidity index
or in days since onset to diagnosis. Patients with poor clinical
course had poorer initial renal function, signiﬁcantly higher
leucocyte and neutrophil blood counts and higher LDH and
C-reactive protein concentrations than patients with good
clinical course, although the differences in these 2 parameters
were not statistically signiﬁcant.
The extent of ischaemic damage assessed by CT was sig-
niﬁcantly higher in patients with a worse clinical course.
Also of note was the greater use of prior oral anticoagula-
tion in ARI patients with a good clinical course
Table 3 shows the degree of association of each
of the variables assessed with poor combined outcome.
The table also details the variables that went into the
improved poor combined outcome predictive multivariate
model.
The separate analysis of the cause of death within 6 months
(8 cases) revealed the comorbidity index to be the only vari-
able signiﬁcantly associated with mortality (OR = 1.60; 95% CI:
1.07–2.41; p = 0.023).
The causes of persistent renal function impairment after
excluding mortality at 6 months were the initial glomerular ﬁl-
tration (OR = 0.804; 95% CI: 0.695–0.930; p = 0.003) and the prior
prescription of anticoagulants (OR = 0.037; 95% CI: 0.002–0.803;
p = 0.036).
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Table 3 – Univariate and multivariate logistic regression model of unfavourable combined outcomes (death or permanent
renal function impairment) associated with acute renal infarction.
Variable Univariate Multivariatea
OR (95% CI) p OR (95% CI) p
Age (years) 0.955 (0.886–1.030) 0.233
Gender (male) 1.004 (0.207–4.883) 0.996
Comorbidity, Charlson index 1.592 (1.036–2.447) 0.034
Antiplatelet therapy (male) 0.412 (0.086–1.972) 0.412
Anticoagulation therapy (male) 0.054 (0.008–0.371) 0.003 0.135 (0.032–0.565) 0.006
Diagnostic delay, in days 1.188 (0.766–1.843) 0.442
Glomerular ﬁltration, per ml/min/1.73 m2 0.927 (0.881–0.975) 0.003 0.949 (0.918–0.980) 0.002
LDH, in IU/ml 1.000 (0.998–1.002) 0.980
Total white blood cell count (per 1000/mm3) 1.237 (1.028–1.489) 0.024
n (fora Variables chosen automatically by conditional progressive inclusio
95% CI, 95% conﬁdence interval; OR, odds ratio.
Discussion
The results of this study show that ARI is an infrequent diag-
nosis, with non speciﬁc clinical manifestations and it is often
associated to comorbid conditions (heart disease, arrhythmia,
etc.), which eventually help the physicians to suspect the diag-
nosis. However, it is important to point out that more  than half
of the patients studied, particularly younger patients, had no
associated cardiac conditions.
Approximately, 40% of patients had an unfavourable out-
come in terms of survival or permanent renal impairment, and
the main factors that determine poor outcome were the renal
function at time of diagnosis and the lack of oral anticoagulant
therapy prior to the onset of ARI.
This study compiled one of the largest series of ARI pub-
lished cases at a single hospital site. Given that the population
covered by the Hospital Ramón y Cajal is approximately
600,000, the prevalence of ARI can be estimated to be about
5.7 cases per million population/year. The actual frequency
of ARI is probably higher taking into account the increase
proportion of ageing population and the high prevalence of
cardiovascular disease treated at the hospital, as well as
potential unrecognised cases due to lack of ARI symptoms.2 It
is impossible to determine whether the increasing prevalence
of ARI throughout a given study period should be attributed
to greater medical awareness or to an actual increase in ARI
cases.
In our series, cardioembolic disease associated with atrial
ﬁbrillation was the most common cause of ARI. These ﬁndings
differ from other reports by other, who found the most com-
mon aetiology is thrombosis caused by damage to the renal
artery.4,5
Even after exhaustive diagnostic studies, the cause of ARI
could not be determined in 4 cases.12,13 This diagnosis requires
a high degree of suspicion in patients presenting with abdomi-
nal pain and particularly ﬂank pain, and especially for patients
with cardiovascular risk factors or at risk of suffering a throm-
botic event.6,14Renal function impairment in the context of ARI is largely
due to renal hypoperfusion, although the associated symp-
toms (vomiting, reduced oral intake), or the use of intravenous
contrast agents may be contributing factors. Determinationwards) and p of at least <0.01.
of LDH has been shown to be a key diagnostic factor, as it
increases in the ﬁrst 24 h and may remain high for up to 2
weeks.6,9,15
A urinalysis may also be useful in conﬁrming a diagnosis.
It has been reported that a bilateral obstruction of the renal
arteries yields to a urine with sodium, creatinine and urea con-
centrations similar to plasma concentrations.16 Conversely,
urine LDH levels may be higher than in plasma in cases of renal
ischaemia.15 Urinalysis was not available in many  patients in
this study, nor was it possible to determine the proportion of
patients with oliguria or haematuria. For this reason, urine
was not included as a variable y the present study.
Diagnostic imaging is required to conﬁrm an ARI diagno-
sis. There is no consensus in the literature as to the imaging
technique of choice for a correct diagnosis, though most series
used abdominal contrast-enhanced CT scan.4,6,7,9,17,18
A contrast-enhanced CT scan reveals perfusion defects,
sometimes accompanied by cortical rim sign, which corre-
spond to the blood ﬂow through collateral arteries19 (Fig. 2). If,
intravenous contrast is not used, ARI may not be recognised.20
An angiography, on the other hand, is a diagnostic con-
ﬁrmation test, which also provides the location and extent
of arterial occlusion in more  detail. But the associated risks
are also greater, including nephrotoxicity caused by greater
exposure to the radiocontrast agent, atheroembolism or
artery ruptures.13 Alternative techniques include radioisotope
renography or renal Doppler ultrasound, although the latter,
despite being affordable and safe, has not been proven to be
sufﬁciently sensitive.9 Contrast-enhanced ultrasound seems
to produce better results, but broader experience is required
to validate its effectiveness as a diagnostic test.21
In this study, all cases were diagnosed with contrast-
enhanced CT scan. The extent of ischaemic damage was
similar in the cardiac and non-cardiac ARI subgroups, with
ﬁndings similar to those reported from other series.20
Possible treatments include systemic anticoagulation, ﬁbri-
nolysis and even open surgery in extremely rare cases.
Fibrinolysis seems to be a good alternative, although time
since onset and patient comorbidity should be taking into
22,23consideration before indicating ﬁbrinolysis.
Systemic anticoagulation is the standard treatment, espe-
cially for ARI of cardiac origin. In our series, just 4 patients
underwent local ﬁbrinolysis with urokinase infusion. In these
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ases, ARI diagnosis was made in an inpatient setting due to
ther causes, with just a few hours of delay in the diagnosis.
A noteworthy ﬁnding was the improved outcome of
atients who were receiving anticoagulation therapy prior to
RI, despite the fact that prothrombin times were not always
ithin optimal anticoagulation range. Hypotheses to justify
his ﬁnding include: stronger diagnostic suspicion of ARI;
maller thrombi; and easiness and speed of achieve effective
nticoagulation.
Thirty percent of patients diagnosed with ARI in our series
emained with renal function impairment (CKD) 6 months
fter onset, which is similar to the ﬁndings in other studies.9,24
t has been reported that elevated creatinine levels at the onset
redicts CKD.24 Patients frequently develop hypertension that
s refractory to treatment.25
Overall mortality in this study was 13%, probably ARI was
ot the trigger of death but a consequence of the severe dis-
ase that the patient had (advanced cancer, sepsis or severe
ortic dissection).5 The presence of extrarenal embolisms
esulted in increased morbidity/mortality and length of hos-
ital stay. Other studies have reported patient death after
ospital discharge caused by ischaemic injury to other vital
rgans,18 which highlights the importance of correctly inves-
igating embolic factors or the underlying cause of ARI in order
o reduce associated mortality rates.5
This study has certain limitations. It is a retrospective
tudy at a single hospital site, and it was not possible to
ollect data on all the variables from all the patients. Further-
ore,  diagnosis and follow-up was carried out by numerous
edical teams, which means that patient management was
either uniform nor standardised by a protocol. The estimated
xtent of ischaemic damage by CT scan was not conducted
sing highest-precision methods (approximate estimation),
lthough the signiﬁcant correlation with baseline renal func-
ion is noteworthy.
In conclusion, although ARI is not a commonly diagnosed
athology, it should always be considered in the event of man-
festation of certain symptoms or biochemical abnormalities,
ncluding in patients without a clinical history of heart dis-
ase or arrhythmia. Partial or total permanent kidney injury
s a common complication, and early treatment could help to
educe the extent and severity of ischaemic renal damage.
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